Vicky Mollaki studied Genetics in Cardiff University, UK, and received her MSc in Molecular and Genetic Medicine from Sheffield University, UK. She completed her doctorate in 2006 at Sheffield University, UK, in Molecular Genetics. She is a Researcher (Level C) in Research Ethics of Digital Technologies and Biotechnology at the Institute of Informatics and Telecommunications (ΙΙΤ) of the National Centre for Scientific Research “Demokritos” (NCSRD), where she coordinates the CHANGER EU-funded project developing novel methodologies for ethics reviews. Since 2016 she has been also appointed as external Ethics Expert in the European Commission, carrying out ethics evaluations for research programs. As a visiting Professor she teaches ethics-related courses at the International Hellenic University and the Open University of Cyprus.

Adrien Bottacci is a PhD candidate in public law from Aix-Marseille Université, France (UMR 7268 ADES, CDSA Health Law Centre and UMR 7318 DICE CERIC International, Comparative and European Laws). His research focuses on the regulation of stem cell research and more particularly on ethically sensitive models such as neural organoids, stem cell-based embryo models and chimeras. He is part of the French ANR project “Organact” which takes an interdisciplinary approach combining sociology, anthropology and law to examine human organoids and the issues raised by their production, circulation and use.

Prof. Kris Dierickx is Full Professor of Medical Ethics at the Faculty of Medicine at KU Leuven. His research focuses on the applied and fundamental aspects of new technologies in medicine. His main research activities are concentrated on the ethical aspects of predictive medicine, financial incentives, organoids, on research ethics, and on scientific integrity. He acts as a reviewer for various journals and has published more than 200 articles in international peer reviewed journals and books.

Ophélie Sauzeau is a PhD student at the Centre for Biomedical Ethics and Law (KU Leuven, Belgium), under the supervision of Professor Pascal Borry, within the Marie Skłodowska-Curie Action IMPLANTEU project funded by the European Commission. Her research focuses on the ethical aspects of stem cell-based embryo models (embryoids). She holds two Master’s degrees from Université Paris-Saclay in Reproductive and Developmental Biology and in Ethics of Scientific Research, with a specialization in the ethical challenges posed by reproductive technologies. She has studied in France, Canada, and the United States, and is a member of the PGT-A ethics group of the French Federation of Human Genetics (FFGH). She is also training to become a European Commission Ambassador for Non-Animal Methods (NAMs), promoting innovative and ethical alternatives to animal experimentation.

Pascal Borry is professor of bioethics at the Centre for Biomedical Ethics and Law (University of Leuven, Belgium). His main research activities are concentrated on the ethical, legal and social implications of innovative technologies. He is member of the Belgian Consultative Committee on Bioethics and member of the Research Ethics Committee of UZ/KU Leuven. He is currently chair of the WADA Independent Ethics Board. He is also chair of the Department of Public Health and Primary Care of KU Leuven since 2020.

Margaux Reckelbus is currently a Ph.D. student at the Centre for Biomedical Ethics and Law in the Department of Public Health and Primary Care at KU Leuven University in Belgium. Her research focuses on the ethical, legal, and societal challenges of gene therapy, with a particular interest in how stakeholders experience issues related to access, safety, and regulatory oversight of these innovative treatments. She holds a Bachelor’s degree in Law and a Master’s degree in Population Sciences and Development.

Kaatje Goossens obtained her bachelor’s degree (2022) and master’s degree (2024) in Biomedical Sciences from the Catholic University of Leuven. In October 2024, she joined the Centre for Biomedical Ethics and Law (CBMER) as a research assistant working on the AI-POD project, which focuses on developing AI-based tools to predict obesity-related vascular diseases. Her work within this project centred and centres on the ethical aspects of tool development and stakeholder perspectives. In October 2025, Kaatje was awarded a PhD Fundamental Research Mandate from the Research Foundation – Flanders (FWO), through which she conducts doctoral research on the ethical and practical aspects of post-mortem tissue donation in breast cancer.